The Bancorp trades as part of the financial services sector and trades as part of the banking industry. The company CEO is Damian Kozlowski. The Bancorp Inc through its subsidiary is engaged in specialty lending: securities backed lines of credit, or SBLOC, automobile fleet and other equipment leasing, Small Business Administration, or SBA.
Previous Intraday Performance:
The TBBK shares had a previous change of 0.91% which opened at 8.75 and closed at 8.84. It moved to an intraday high of 8.91 and a low of 8.74.
Over the last five trading days, TBBK shares returned 2.08% and in the past 30 trading days it returned 4.25%. Over three months, it changed 2.08%. In one year it has changed -19.42% and within that year its 52-week high was 12.00 and its 52-week low was 7.64. TBBK stock is 15.71% above its 52 Week Low.
Our calculations result in a 200 day moving average of 9.69 and a 50 day moving average of 8.74. Right now, TBBK stock is trading -8.79% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $499.0m with 56.4m shares outstanding and a float of 52.5m shares. Trading volume was 66,110 shares and has experienced an average volume of 113,915 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for The Bancorp was 1.56 which ended on 31st of December 2018, which according to the previous close, that is a PE of 5.67. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.18. The trailing twelve month EPS is 0.70, which comes to a trailing twelve month PE of 12.63.
Below was the last reported quarterly earnings per share:
The next earnings report will be: 03-25-2019
The long-term trend of the EPS is an important number as it indicates the present value of The Bancorp; it is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been 20.80% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 7.00% of insider ownership and 113.50% of institutional ownership.
I calculated the beta to be 1.20
SeekingAlpha: VBI Vaccines reports FY results
Based on last reported financials, the company’s return on equity is 24.26%, return on assets is 1.94%, profit margin is 30.19%, price-to-sales is 1.68 and price-to-book is 1.22.
Company Score Card:
Results are out of six:
0 : Growth Expectations Result
6 : Financial Safety Result
5 : Past Performance Result
3 : Valuation Result
0 : Dividend Safety Result
3 : Overall Result